Alzchem Group Ag Stock Performance
| ALZCF Stock | USD 166.85 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.51, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning AlzChem Group are expected to decrease at a much lower rate. During the bear market, AlzChem Group is likely to outperform the market. At this point, AlzChem Group AG has a negative expected return of -0.0056%. Please make sure to confirm AlzChem Group's jensen alpha, and the relationship between the standard deviation and kurtosis , to decide if AlzChem Group AG performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days AlzChem Group AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, AlzChem Group is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 17.1 M | |
| Total Cashflows From Investing Activities | -28.5 M |
AlzChem |
AlzChem Group Relative Risk vs. Return Landscape
If you would invest 16,950 in AlzChem Group AG on September 29, 2025 and sell it today you would lose (265.00) from holding AlzChem Group AG or give up 1.56% of portfolio value over 90 days. AlzChem Group AG is currently producing negative expected returns and takes up 1.882% volatility of returns over 90 trading days. Put another way, 16% of traded pink sheets are less volatile than AlzChem, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
AlzChem Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AlzChem Group's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as AlzChem Group AG, and traders can use it to determine the average amount a AlzChem Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.003
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALZCF |
Based on monthly moving average AlzChem Group is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AlzChem Group by adding AlzChem Group to a well-diversified portfolio.
AlzChem Group Fundamentals Growth
AlzChem Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of AlzChem Group, and AlzChem Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AlzChem Pink Sheet performance.
| Return On Equity | 0.27 | |||
| Return On Asset | 0.0508 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 276.28 M | |||
| Shares Outstanding | 10.14 M | |||
| Price To Earning | 9.34 X | |||
| Price To Book | 2.89 X | |||
| Price To Sales | 0.52 X | |||
| Revenue | 422.29 M | |||
| EBITDA | 62.69 M | |||
| Cash And Equivalents | 6.91 M | |||
| Cash Per Share | 0.68 X | |||
| Total Debt | 37.55 M | |||
| Book Value Per Share | 13.74 X | |||
| Cash Flow From Operations | 43.02 M | |||
| Earnings Per Share | 2.96 X | |||
| Total Asset | 377.67 M | |||
About AlzChem Group Performance
By analyzing AlzChem Group's fundamental ratios, stakeholders can gain valuable insights into AlzChem Group's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AlzChem Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AlzChem Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AlzChem Group AG develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany. Alzchem Group operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 1464 people.Things to note about AlzChem Group AG performance evaluation
Checking the ongoing alerts about AlzChem Group for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for AlzChem Group AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AlzChem Group AG generated a negative expected return over the last 90 days | |
| About 53.0% of the company shares are held by company insiders |
- Analyzing AlzChem Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AlzChem Group's stock is overvalued or undervalued compared to its peers.
- Examining AlzChem Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AlzChem Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AlzChem Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AlzChem Group's pink sheet. These opinions can provide insight into AlzChem Group's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AlzChem Pink Sheet analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |